Skip to main content
. 2020 Jul 24;12(14):14232–14243. doi: 10.18632/aging.103440

Figure 5.

Figure 5

Mino administration inhibited IL-1β release. (A) Qualitative analysis of IL-1β in the SN. *P < 0.05; **P < 0.01. (B) IL-1 receptor immunostaining in dopaminergic neurons in the substantia nigra (SN).